Site Watch

Category

OneOncology Expands to Southern California with the Los Angeles Cancer Network Joining the Platform for a Win-Win

OneOncology incorporated yet another community oncology provider, Los Angeles Cancer Network (LACN), into its growing network nationwide. This private equity-based group is developing an important model. OneOncology, on the one hand, seeks to embrace the realities of...

ICU’s Collaborating Worldwide: Hartford Hospital Joins COVID-19 Critical Care Consortium Study & Pursuit of Real World Evidence

Hartford Hospital, one of New England’s largest teaching hospitals and tertiary care centers with perhaps one of the region’s busiest surgery practices, joined the COVID-19 Critical Care Consortium (COVID Critical), an alliance of clinicians and scientists dedicated...

Upstate Medical University Selected by “Project Lightspeed” & Treats First Four Patients with BNT162 COVID-19 Vaccine

Upstate Medical University was selected by the Pfizer and BioNTech partnership to participate in the Phase 3 clinical trial assessing the safety and efficacy of the German company’s BNT162 vaccine targeting the novel coronavirus. Four vaccines in the BNT162 portfolio,...

NCI Renews Huntsman Cancer Institute Prestigious Designated Comprehensive Cancer Center Status: $29m & Near Perfect Ranking

Huntsman Cancer Institute (HCI) actually provides cancer research to nearly 20% of the lower 48 states of America, meaning that those that live in a massive section of the Intermountain West, from Wyoming, Montana and Idaho to Utah, eastern Nevada and western...

Accel Clinical Services to Conduct the Pivotal mRNA-1273 COVID-19 Vaccine Trial in Central Florida

Accel Clinical Services, a private equity-backed network of clinical trial sites dedicated to the expert delivery of treatment options to patients and providers, was selected to participate in the pivotal Phase 3 clinical trial sponsored by Moderna to test the safety...

Low-Cost Steroid Going on NIH Clinical Guidelines for Ill COVID-19 Patients in Need of Ventilator: Lives will be Saved Thanks to Oxford Study

The University of Oxford sponsored the RECOVERY trial, which led to the recent findings that dexamethasone lowers the death rate for severe to critically ill COVID-19 patients receiving mechanical ventilation versus the standard of care. In conjunction with the...

Pin It on Pinterest